Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$136,304,000
+$30,848,000 QoQ
Shares Held
1,600,000
0.0% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
5.59%
of 13F equity value
Holder Rank
#18
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Mar 31, 2026CallValue
$65,910,000
CallShares
1,000,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Integral Health Asset Management, LLC holds $1,502,601,600 across 54 Biotechnology names. CYTK ranks #3 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
1,500,000 | $280,920,000 | |
| 2 | INSM |
INSMED Inc
|
1,600,000 | $170,592,000 | |
| 3 | CYTK |
Cytokinetics Inc
This page
|
1,600,000 | $136,304,000 | |
| 4 | EWTX |
Edgewise Therapeutics, Inc.
|
2,000,000 | $81,260,000 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
1,750,000 | $75,092,500 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
300,000 | $73,431,000 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,000,000 | $70,780,000 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
550,000 | $61,066,500 |
All Filings in CYTK
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,304,000 | 1,600,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $65,910,000 | 1,000,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $105,456,000 | 1,600,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $88,956,000 | 1,400,000 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $31,770,000 | 500,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $41,220,000 | 750,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $76,944,000 | 1,400,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,520,000 | 500,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $33,040,000 | 1,000,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $44,209,000 | 1,100,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $47,040,000 | 1,000,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $39,600,000 | 750,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $54,180,000 | 1,000,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $31,549,500 | 450,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $33,396,000 | 400,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $8,349,000 | 100,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $16,698,000 | 200,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $23,568,000 | 800,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $21,203,000 | 650,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $21,114,000 | 600,000 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $18,328,000 | 400,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $16,957,500 | 350,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,627,250 | 525,000 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $17,300,700 | 470,000 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $14,813,500 | 325,000 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $11,615,500 | 325,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,853,000 | 700,000 | Shares | Sole | 2021-08-30 | |
| 2021-03-31 | $16,282,000 | 700,000 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $10,909,500 | 525,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,330,000 | 200,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $8,013,800 | 340,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,772,800 | 320,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||